Para acceder a los documentos con el texto completo, por favor, siga el siguiente enlace: http://hdl.handle.net/2445/110769

Ivermectin to reduce malaria transmission II. Considerations regarding clinical development pathway
Chaccour, Carlos; Rabinovich, N. Regina
The development of ivermectin as a complementary vector control tool will require good quality evidence. This paper reviews the different eco-epidemiological contexts in which mass drug administration with ivermectin could be useful. Potential scenarios and pharmacological strategies are compared in order to help guide trial design. The rationale for a particular timing of an ivermectin-based tool and some potentially useful outcome measures are suggested.
Malària
Assaigs clínics
Malaria
Clinical trials
cc by (c) Chaccour et al., 2017
http://creativecommons.org/licenses/by/3.0/es/
Artículo
info:eu-repo/semantics/publishedVersion
Biomed Central
         

Mostrar el registro completo del ítem

Documentos relacionados

Otros documentos del mismo autor/a

Chaccour, Carlos; Rabinovich, N. Regina; Slater, Hannah; Canavati, Sara E.; Bousema, Teun; Lacerda, Marcus; Ter Kuile, Feiko; Drakeley, Chris; Bassat Orellana, Quique; Foy, Brian D.; Kobylinski, Kevin
Bassat Orellana, Quique; Ordi i Majà, Jaume; Vila Estapé, Jordi; Ismail, Mamudo R.; Carrilho, Carla; Lacerda, Marcus V. G.; Munguambe, Khátia; Odhiambo, Frank O.; Lell, Bertrand; Sow, Samba; Bhutta, Zulfiqar A.; Rabinovich, N. Regina; Alonso, Pedro; Menéndez, Clara
Galatas, Beatriz; Nhamussua, Lidia; Candrinho, Baltazar; Mabote, Lurdes; Cisteró, Pau; Gupta, Himanshu; Rabinovich, N. Regina; Menéndez, Clara; Macete, Eusébio; Saute, Francisco; Mayor Aparicio, Alfredo Gabriel; Alonso, Pedro; Bassat Orellana, Quique; Aide, Pedro